Scope of Study definition

Scope of Study means the research project to be performed by the Partners entitled, [“INSERT PROJECT TITLE”], which is attached hereto as Appendix l and incorporated herein by reference.
Sample 1
Scope of Study. The proposed area for the location of the rowing facility is Rotary Park and vacant City property adjacent to Rotary Park extending north to the Trade Center. The study may encompass property outside this area as necessary to accommodate the required elements to facilitate rowing activities and competitions.
Sample 1
Scope of Study is a proposal that describes the research to be performed by the Partner(s), the identities and/or descriptions of the personnel working on Scope of Study, and the financial support requested of the UC Irvine Vision Research Consortium for the performance of its studies.
Sample 1

Examples of Scope of Study in a sentence

  • I-3Product Definitions and Scope of Study..................................

  • The number of deaths at the county level number is mainly collected from the population statistical books published by the provincial Statistics Bureaus in the 1980s.11 Scope of Study.

  • Research Methodology 97– 100 4.1 Title of the Study 4.2 Duration of the Project 4.3 Objective of Study 4.4 Type of Research 4.5 Sample Size and method of selecting sample 4.6 Scope of Study 4.4.7 Limitation of StudyFacts and Findings 101 – 1045.Analysis and Interpretation105-1206.SWOT121-1227.Conclusion1238.Recommendation and Suggestions124-1259.Appendix – Questionnaire126- 12810.

  • On December 13, 2019, OEA published theFinal Scope of Study in the Federal Register (84 FR 68274).

  • Based on the information obtained, SEA developed a Scope of Study identifying the specific topics, issues, and environmental resources to be discussed in the EIS.

  • CONTENTS Page ABSTRACT 1 INTRODUCTION 2 Background 2 Scope of Study 2 Physical Setting of Study Area 4 Acknowledgments 4 HISTORICAL SUMMARY OF DEWATERING DEVELOPMENT.

  • OEA considered all the of the comments and revised the Draft Scope of Study in response to public and agency input.

  • Any deviation from the standard ITE trip rates must be proposed as part of the Scope of Study.

  • The Scope of Study shall include: a description of the proposed project; definition of the traffic impact study area; proposed locations for automatic traffic recorder and intersection turning movement counts; timeframe of the data collection program identifying any weekday, weekend, or seasonal considerations; and identification and justification for any proposed deviations from the traffic impact study criteria presented herein.

  • Institutional and financial sustainability in this case are presented as the dependent variables that are presumably affected by the four components of strategies of implementation, resource mobilisation, legal environment and ownership of organisation.1.8 Scope of Study 1.8.1 Geographical Scope of Study Geographically, this study was conducted in Gulu District, which is located in Northern Uganda.


More Definitions of Scope of Study

Scope of Study means the projects and tasks, and associated Research Costs, specified in an approved Annual Research Plan and Budget for performance by Investigators at an individual Member Institution. “University’s Scope of Study” means the Scope of Study the responsibility for the performance of which the Consortium Committee allocates Investigators at University, subject to University’s review and approval as set forth in Section 3.2(ii).
Sample 1
Scope of Study. This section should set out the scope of the learning requirements for the placement. • [In many cases it is likely that an established relationship will already exist between the Organisational Unit and the Work Placement Provider. In such cases, it is likely that the learning requirements are already well known]. • [If a new Work Placement Provider is involved, it is recommended that the Organisational Unit contact should discuss with the organisation’s placement contact what is expected from the placement and whether a written program of study should be developed. Issues to be covered could include: o what types of information and knowledge staff members share with students; o what, if any, form of report will be required on completion of the placement; and/or o any confidentiality requirements from the students]. The Organisational Unit will provide academic and other support to the student over the course of the work placement. The Organisational Unit contact will be available to provide advice to the student or the Work Placement Provider over the course of the placement. [An initial discussion between the Organisational Unit contact and Work Placement Provider contact is often advisable prior to the commencement of the placement].
Sample 1

Related to Scope of Study

  • Program of study means a curriculum that requires a candidate to demonstrate and document competency in the specific knowledge, skills, and dispositions for a particular endorsement to an educator’s license, a licensure content area, or level of licensure, and is:

  • Phase 2 Clinical Trial means a human clinical trial, for which the primary endpoints include a determination of dose ranges or an indication of efficacy in patients being studied as described in 21 C.F.R. §312.21(b), or an equivalent clinical trial in a country in the Territory other than the United States.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Subject of a Clinical Trial means the health care service, item, or drug that is being evaluated in the Approved Clinical Trial and that is not a Routine Patient Cost.

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Clinical Trial means any human clinical trial of a Product.

  • Pivotal Clinical Trial means a human clinical trial in any country that is prospectively designed to generate data intended to satisfy the requirements of 21 C.F.R. § 312.21(c) (as amended) in the U.S. or a similar clinical study prescribed by a Regulatory Authority from another country, from time to time, pursuant to Applicable Law.

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.

  • Phase 2 Trial means a human clinical trial conducted on study subjects with the disease or condition being studied for the principal purpose of achieving a preliminary determination of efficacy or appropriate dosage ranges, as further described in 21 C.F.R. §312.21(b) (including any such clinical study in any country other than the United States).

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Phase 3 Trial means a human clinical trial of a Product on a sufficient number of subjects that is designed to establish that a pharmaceutical product is safe and efficacious for its intended use, and to determine warnings, precautions and adverse reactions that are associated with such pharmaceutical product in the dosage range to be prescribed, which trial is intended to support Approval of a Product, as described in 21 C.F.R. 312.21(c) for the United States, or a similar clinical study prescribed by the Regulatory Authorities in a foreign country.

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Board of Studies means the Board of Studies of the University;

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Pivotal Study means (a) a Phase 3 Study that is intended by Celgene to be submitted (together with any other registration trials that are prospectively planned when such Phase 3 Study is initiated) for Regulatory Approval in the U.S. or the EU, or (b) any other clinical study that is designed to establish that a pharmaceutical product is safe and efficacious for its intended use, and to determine warnings, precautions, and adverse reactions that are associated with such pharmaceutical product in the dosage range to be prescribed, which clinical study is a registration trial intended to be sufficient for filing an application for a Regulatory Approval for the Licensed Product in the U.S. or another country or some or all of an extra-national territory, solely as evidenced by the acceptance for filing for a Regulatory Approval for such product after completion of such study.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Study means the investigation to be conducted in accordance with the Protocol.

  • Feasibility Study means the evaluation and analysis of the potential of a project, which aims at supporting the process of decision-making by objectively and rationally uncovering its strengths and weaknesses, opportunities and threats, as well as identifying the resources required to carry it through and ultimately its prospects for success;

  • Phase 1 Trial means, with respect to a Licensed Product, a clinical trial (or — in case of a multi-phase clinical trial — those parts of a clinical trial) in line with the provisions of 21CFR312, Section 21 (a).

  • Phase III Clinical Trial means a human clinical trial of a product, the design of which is acknowledged by the FDA to be sufficient for such clinical trial to satisfy the requirements of 21 C.F.R. 312.21(c) (as amended or any replacement thereof), or a similar human clinical trial prescribed by the Regulatory Authority in a country other than the United States, the design of which is acknowledged by such Regulatory Authority to be sufficient for such clinical trial to satisfy the requirements of a pivotal efficacy and safety clinical trial.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Phase IV Clinical Trial means a product support clinical trial of a Product commenced after receipt of Regulatory Approval in the country where such trial is conducted. A Phase IV Clinical Trial may include epidemiological studies, modeling and pharmacoeconomic studies, and investigator-sponsored clinical trials studying Product that are approved by the JDC and that otherwise fit the foregoing definition.